QQQ   414.08 (-2.20%)
AAPL   164.94 (-1.26%)
MSFT   398.78 (-1.36%)
META   479.54 (-4.44%)
GOOGL   153.73 (-1.46%)
AMZN   174.12 (-2.85%)
TSLA   146.72 (-2.14%)
NVDA   760.89 (-10.14%)
AMD   146.70 (-5.40%)
NIO   3.79 (-5.25%)
BABA   69.02 (+0.20%)
T   16.49 (+0.98%)
F   12.12 (+0.50%)
MU   106.91 (-4.48%)
GE   147.81 (-3.35%)
CGC   7.94 (+1.40%)
DIS   112.36 (-0.06%)
AMC   3.15 (+7.88%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.92 (+1.18%)
QQQ   414.08 (-2.20%)
AAPL   164.94 (-1.26%)
MSFT   398.78 (-1.36%)
META   479.54 (-4.44%)
GOOGL   153.73 (-1.46%)
AMZN   174.12 (-2.85%)
TSLA   146.72 (-2.14%)
NVDA   760.89 (-10.14%)
AMD   146.70 (-5.40%)
NIO   3.79 (-5.25%)
BABA   69.02 (+0.20%)
T   16.49 (+0.98%)
F   12.12 (+0.50%)
MU   106.91 (-4.48%)
GE   147.81 (-3.35%)
CGC   7.94 (+1.40%)
DIS   112.36 (-0.06%)
AMC   3.15 (+7.88%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.92 (+1.18%)
QQQ   414.08 (-2.20%)
AAPL   164.94 (-1.26%)
MSFT   398.78 (-1.36%)
META   479.54 (-4.44%)
GOOGL   153.73 (-1.46%)
AMZN   174.12 (-2.85%)
TSLA   146.72 (-2.14%)
NVDA   760.89 (-10.14%)
AMD   146.70 (-5.40%)
NIO   3.79 (-5.25%)
BABA   69.02 (+0.20%)
T   16.49 (+0.98%)
F   12.12 (+0.50%)
MU   106.91 (-4.48%)
GE   147.81 (-3.35%)
CGC   7.94 (+1.40%)
DIS   112.36 (-0.06%)
AMC   3.15 (+7.88%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.92 (+1.18%)
QQQ   414.08 (-2.20%)
AAPL   164.94 (-1.26%)
MSFT   398.78 (-1.36%)
META   479.54 (-4.44%)
GOOGL   153.73 (-1.46%)
AMZN   174.12 (-2.85%)
TSLA   146.72 (-2.14%)
NVDA   760.89 (-10.14%)
AMD   146.70 (-5.40%)
NIO   3.79 (-5.25%)
BABA   69.02 (+0.20%)
T   16.49 (+0.98%)
F   12.12 (+0.50%)
MU   106.91 (-4.48%)
GE   147.81 (-3.35%)
CGC   7.94 (+1.40%)
DIS   112.36 (-0.06%)
AMC   3.15 (+7.88%)
PFE   25.96 (+2.24%)
PYPL   61.96 (-0.23%)
XOM   119.92 (+1.18%)
Free Trial
NASDAQ:ZFGN

Zafgen (ZFGN) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free ZFGN Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$6.33
▼
$7.00
50-Day Range
$0.99
▼
$25.06
52-Week Range
$0.62
▼
$2.76
Volume
510,792 shs
Average Volume
360,199 shs
Market Capitalization
$239.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsSocial Media
ZFGN stock logo

About Zafgen Stock (NASDAQ:ZFGN)

Zafgen, Inc., a clinical-stage biopharmaceutical company, develops therapies for patients suffering from metabolic diseases comprising type 2 diabetes, Prader-Willi syndrome (PWS), and other metabolically related disorders. The company's lead product candidate is ZGN-1061, a fumagillin-class methionine aminopeptidase 2 (MetAP2) inhibitor administered by subcutaneous injection, which is in Phase 2 clinical trial and profiled for its utility in the treatment of type 2 diabetes and other related metabolic disorders. It also develops ZGN-1258, a MetAP2 inhibitor for treatment of PWS. Zafgen, Inc. was founded in 2005 and is headquartered in Boston, Massachusetts.

ZFGN Stock News Headlines

April 9, 2023 | marketwatch.com
Global Weight Loss Therapeutics Professional Market 2023 (Exclusive Report) | Future Work Trend by 2030
February 26, 2023 | thestreet.com
Zafgen (ZFGN) Stock Skyrockets on Positive Obesity Drug Results
April 19, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
January 13, 2023 | thestreet.com
Zafgen (ZFGN) Stock Surges on Positive Obesity Drug Trial
November 8, 2022 | bbc.co.uk
Food and drink in a castle
September 30, 2022 | seekingalpha.com
LRMR Larimar Therapeutics, Inc.
September 14, 2022 | streetinsider.com
Form 424B5 Larimar Therapeutics, - StreetInsider.com
April 12, 2022 | streetinsider.com
Form DEF 14A Larimar Therapeutics, For: May 10 - StreetInsider.com
April 19, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
March 25, 2022 | marketscreener.com
LARIMAR THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K) - Marketscreener.com
November 12, 2021 | marketscreener.com
LARIMAR THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com
November 12, 2021 | streetinsider.com
Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results - StreetInsider.com
November 12, 2021 | globenewswire.com
Larimar Therapeutics Reports Third Quarter 2021 Operating - GlobeNewswire
October 22, 2021 | finance.yahoo.com
Anti-Obesity Therapeutics Market Research Report by Mechanism of Action, by Drug Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo Finance
October 20, 2021 | benzinga.com
Anti-Obesity Therapeutics Market Research Report by Mechanism of Action, by Drug Type, by Region - Global - Benzinga
September 21, 2021 | streetinsider.com
Fauna Bio Raises $9 Million to Expand Comparative Genomics Platform for Novel Target Discovery - StreetInsider.com
September 21, 2021 | prnewswire.com
Fauna Bio Raises $9 Million to Expand Comparative Genomics Platform for Novel Target Discovery - PRNewswire
August 2, 2021 | seekingalpha.com
Vividion Therapeutics Begins U.S. IPO Effort - Seeking Alpha
See More Headlines
Receive ZFGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zafgen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2020
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZFGN
CUSIP
N/A
CIK
1374690
Web
www.zafgen.com
Phone
617-622-4003
Fax
N/A
Employees
38
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-45,410,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-51.34%
Return on Assets
-34.55%

Debt

Debt-to-Equity Ratio
0.26
Current Ratio
6.56
Quick Ratio
6.56

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.35 per share
Price / Book
4.73

Miscellaneous

Outstanding Shares
37,470,000
Free Float
N/A
Market Cap
$239.06 million
Optionable
Not Optionable
Beta
0.27
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Jeffrey S. Hatfield (Age 61)
    CEO & Director
  • Ms. Patricia L. Allen (Age 57)
    Chief Financial Officer
  • Dr. Dennis D. Kim M.D. (Age 49)
    MBA, Chief Medical Officer
  • Dr. James E. Vath (Age 58)
    Head of Discovery & Devel.
  • Mr. Brian P. McVeigh (Age 46)
    Chief Bus. Officer

Key Competitors

View All Competitors

ZFGN Stock Analysis - Frequently Asked Questions

How were Zafgen's earnings last quarter?

Zafgen Inc (NASDAQ:ZFGN) released its quarterly earnings results on Thursday, March, 5th. The biopharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.19).

What other stocks do shareholders of Zafgen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zafgen investors own include SCYNEXIS (SCYX), Xtrackers California Municipal Bond ETF (CA), Endologix (ELGX), Energy Transfer (ET), TG Therapeutics (TGTX), BlackRock (BLK), Fate Therapeutics (FATE), Pfizer (PFE), Spectrum Pharmaceuticals (SPPI) and Esperion Therapeutics (ESPR).

This page (NASDAQ:ZFGN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media
My biggest AI fear
Paradigm Press